News from the FDA/CDC
Article
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
The Food and Drug Administration reaffirmed its confidence in the data supporting the claim that rivaroxaban (Xarelto) is a safe and effective...
News from the FDA/CDC
Four of five health care providers get flu shot
Physicians had the highest level of coverage (95.6%), while health care assistants and aides had the lowest (64.5%).
News from the FDA/CDC
FDA approves first-in-class oral antiplatelet drug vorapaxar
The novel antiplatelet drug vorapaxar has been approved for reducing the risk of myocardial infarction, stroke, cardiovascular death, and need for...